Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$666M |
| 2 |
Meta Platforms (Facebook)
META
|
+$652M |
| 3 |
Microsoft
MSFT
|
+$469M |
| 4 |
Amazon
AMZN
|
+$383M |
| 5 |
Salesforce
CRM
|
+$373M |
Top Sells
| 1 |
HEICO Class A
HEI.A
|
+$783M |
| 2 |
Vale
VALE
|
+$398M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$397M |
| 4 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
+$376M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$290M |
Sector Composition
| 1 | Technology | 20.69% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 11.07% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
MaxCyte
MXCT
$156M
| $160K | ﹤0.01% |
32,252
-2,024
| -6% | -$10K |
|
3502
Frontier Group Holdings
ULCC
$1.19B
| $159K | ﹤0.01% |
16,108
+827
| +5% | +$8.14K |
|
|
NCZ
3503
Virtus Convertible & Income Fund II
NCZ
$263M
| $157K | ﹤0.01% |
13,122
-25,233
| -66% | -$303K |
|
3504
Axogen
AXGN
$746M
| $156K | ﹤0.01% |
16,550
-353
| -2% | -$3.34K |
|
3505
Compañía de Minas Buenaventura
BVN
$5.06B
| $156K | ﹤0.01% |
19,053
-2,227
| -10% | -$18.2K |
|
|
AEF
3506
abrdn Emerging Markets Equity Income Fund
AEF
$258M
| $155K | ﹤0.01% |
28,890
-8,844
| -23% | -$47.4K |
|
3507
MBIA
MBI
$384M
| $153K | ﹤0.01% |
16,547
-33,675
| -67% | -$312K |
|
3508
GoodRx Holdings
GDRX
$1.45B
| $151K | ﹤0.01% |
24,108
-8,714
| -27% | -$54.5K |
|
3509
Couchbase
BASE
$1.35B
| $150K | ﹤0.01% |
+10,703
| New | +$150K |
|
3510
Hudson Technologies
HDSN
$441M
| $149K | ﹤0.01% |
17,103
-22,873
| -57% | -$200K |
|
|
YI
3511
111 Inc
YI
$51M
| $149K | ﹤0.01% |
5,607
-385
| -6% | -$10.2K |
|
|
CTIC
3512
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $148K | ﹤0.01% |
35,244
+392
| +1% | +$1.65K |
|
3513
Barclays
BCS
$71.9B
| $148K | ﹤0.01% |
+20,574
| New | +$148K |
|
|
DPG
3514
Duff & Phelps Utility and Infrastructure Fund
DPG
$463M
| $147K | ﹤0.01% |
11,062
+34
| +0.3% | +$453 |
|
|
GRCL
3515
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $146K | ﹤0.01% |
+78,671
| New | +$146K |
|
|
IGMS
3516
DELISTED
IGM Biosciences
IGMS
| $144K | ﹤0.01% |
+10,490
| New | +$144K |
|
|
HIE
3517
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $144K | ﹤0.01% |
+14,318
| New | +$144K |
|
3518
Inspired Entertainment
INSE
$250M
| $143K | ﹤0.01% |
11,163
-4,946
| -31% | -$63.3K |
|
3519
Arbutus Biopharma
ABUS
$855M
| $142K | ﹤0.01% |
46,955
+1,596
| +4% | +$4.84K |
|
3520
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $141K | ﹤0.01% |
13,109
-200,449
| -94% | -$2.16M |
|
3521
Precigen
PGEN
$1.2B
| $139K | ﹤0.01% |
131,072
+88,555
| +208% | +$93.9K |
|
3522
Nuveen Real Estate Income Fund
JRS
$237M
| $138K | ﹤0.01% |
18,495
-28,838
| -61% | -$215K |
|
3523
Senseonics Holdings
SENS
$359M
| $138K | ﹤0.01% |
193,897
+9,455
| +5% | +$6.71K |
|
3524
MiMedx Group
MDXG
$1.02B
| $137K | ﹤0.01% |
40,259
-47,524
| -54% | -$162K |
|
3525
Codexis
CDXS
$220M
| $137K | ﹤0.01% |
33,116
+2,181
| +7% | +$9.03K |
|